1. Lunch symposium I: Zuellig Pharma Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Optimizing IV Iron Treatment in GYN Cancer-related Anemia â´Â Prof. Mongkol Benjapibal, M.D.

2. TGCS business meeting 2021

3. »Ãиҹà»Ô´¡ÒûÃЪØÁ â´Â Gp.Capt. Panon Kasemsarn, M.D. (President of TGCS)

4. Lunch symposium II: Eisai (Thailand) Marketing Co.,Ltd
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ New Approach in the Treatment of Advanced Endometrial Cancer â´Â Assoc. Prof. Arb-aroon Lertkhachonsuk, M.D.

5. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Management of surgical complications: bowel complications â´Â Assoc. Prof. Weerapat Suwanthanma, M.D.

6. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Management of surgical complications: vascular and nerve injury â´Â Kanoklada Srikuea, M.D.

7. Symposium I: MSD (Thailand) Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Impact of HPV Vaccination: A Journey of Prevention â´Â Prof. Jatupol Srisomboon, M.D.

8. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Management of lymphedema â´Â Khemanat Khemworapong, M.D.

9. Sponsor symposium II: Roche Thailand Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ The Evolving of Anti-VEGF in Ovarian Cancer and Management of Cancer Patients in the Covid-19 era. â´Â Assoc. Prof. Wichai Termrungruanglert, M.D.

10. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Detection and management of complications in laparoscopic surgery â´Â Sethawat Sethasathien, M.D.

11. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Care and management of chemotherapy administration â´Â Asst. Prof. Nungrutai Saeaib, M.D.

12. Sponsor symposium III: Pfizer (Thailand) Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Essential Elements of Multimodal Analgesia in Enhanced Recovery After Surgery â´Â Assoc. Prof. Oraluxna Rodanant, M.D.

13. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Management of common side effects after chemotherapy and targeted therapy â´Â Asst. Prof. Woraphot Chaowawanit, M.D.

14. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Wound and ostomy care â´Â Asst. Prof. Palakorn Surakunprapha, M.D.

15. Lunch symposium III: Amgen (Thailand) Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Updates on treatment options for ovarian cancer â´Â Assoc. Prof. Mongkol Benjapibal, M.D.

16. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Practice guideline in management of venous thrombosis â´Â Putsarat Insin, M.D.

17. Sponsor symposium IV: Sanofi-Aventis (Thailand) Ltd.
ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Is VTE prophylaxis necessary for gynecologic surgery? â´Â Assoc. Prof. Piyanut Pootracool, M.D.

18. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Prevention and treatment of radiotherapy complications â´Â Petch Alisanant, M.D.

19. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Management of urological complications during/after surgical staging â´Â Asst. Prof. Col. Satit Siriboonrid, M.D.

20. »Ô´¡ÒûÃЪØÁ